Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swarbrick

Showing results (551-560 of 641) with videos related to

Pageof 65
Sort By:
ACS Central Science|September 30, 2024
Exploring Structure-Activity Relationships and Modes of Action of LaterocidineVarsha J Thombare, James D Swarbrick, Mohammad A K Azad, et al.
British Journal of Cancer|April 10, 2014
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancerH-M Lin, L Castillo, K L Mahon, et al.
Scientific Reports|December 29, 2022
Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cellsHaihong Jin, Nicole A Ladd, Andrew M Peev, et al.
BMJ Open|April 1, 2019
Rationale, design and study protocol of the randomised controlled trial: Diabetes Interventional Assessment of Slimming or Training tO Lessen Inconspicuous Cardiovascular Dysfunction (the DIASTOLIC study)Gaurav Singh Gulsin, Emer M Brady, Daniel J Swarbrick, et al.
Ebiomedicine|May 14, 2017
The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive BehaviorFlorian Weinberg, Nadine Reischmann, Lisa Fauth, et al.
Plos One|December 11, 2013
Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatmentMelissa R Nyendak, Byung Park, Megan D Null, et al.
Plos Genetics|January 3, 2020
ELF5 modulates the estrogen receptor cistrome in breast cancerCatherine L Piggin, Daniel L Roden, Andrew M K Law, et al.
ACS Infectious Diseases|May 29, 2024
Serotype-Specific Regulation of Dengue Virus NS5 Protein Subcellular LocalizationColin Xinru Cheng, Min Jie Alvin Tan, Kitti Wing Ki Chan, et al.
Bioorganic & Medicinal Chemistry|December 18, 2021
Identification and optimization of a novel series of selective PIP5K inhibitorsDavid M Andrews, Sharon Cartic, Sabina Cosulich, et al.
Chemical Communications (Cambridge, England)|December 25, 2013
Potent, selective small molecule inhibitors of type III phosphatidylinositol-4-kinase α- but not β-inhibit the phosphatidylinositol signaling cascade and cancer cell proliferationMichael J Waring, David M Andrews, Paul F Faulder, et al.
Pageof 65

Showing results (551-560 of 641) with videos related to

Sort By:
Pageof 65
ACS Central Science|September 30, 2024
Exploring Structure-Activity Relationships and Modes of Action of LaterocidineVarsha J Thombare, James D Swarbrick, Mohammad A K Azad, et al.
British Journal of Cancer|April 10, 2014
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancerH-M Lin, L Castillo, K L Mahon, et al.
Scientific Reports|December 29, 2022
Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cellsHaihong Jin, Nicole A Ladd, Andrew M Peev, et al.
BMJ Open|April 1, 2019
Rationale, design and study protocol of the randomised controlled trial: Diabetes Interventional Assessment of Slimming or Training tO Lessen Inconspicuous Cardiovascular Dysfunction (the DIASTOLIC study)Gaurav Singh Gulsin, Emer M Brady, Daniel J Swarbrick, et al.
Ebiomedicine|May 14, 2017
The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive BehaviorFlorian Weinberg, Nadine Reischmann, Lisa Fauth, et al.
Plos One|December 11, 2013
Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatmentMelissa R Nyendak, Byung Park, Megan D Null, et al.
Plos Genetics|January 3, 2020
ELF5 modulates the estrogen receptor cistrome in breast cancerCatherine L Piggin, Daniel L Roden, Andrew M K Law, et al.
ACS Infectious Diseases|May 29, 2024
Serotype-Specific Regulation of Dengue Virus NS5 Protein Subcellular LocalizationColin Xinru Cheng, Min Jie Alvin Tan, Kitti Wing Ki Chan, et al.
Bioorganic & Medicinal Chemistry|December 18, 2021
Identification and optimization of a novel series of selective PIP5K inhibitorsDavid M Andrews, Sharon Cartic, Sabina Cosulich, et al.
Chemical Communications (Cambridge, England)|December 25, 2013
Potent, selective small molecule inhibitors of type III phosphatidylinositol-4-kinase α- but not β-inhibit the phosphatidylinositol signaling cascade and cancer cell proliferationMichael J Waring, David M Andrews, Paul F Faulder, et al.
Pageof 65